WO2023037237 - PROCESS FOR THE PREPARATION OF REMIMAZOLAM

National phase entry is expected:
Publication Number WO/2023/037237
Publication Date 16.03.2023
International Application No. PCT/IB2022/058364
International Filing Date 06.09.2022
Title **
[English] PROCESS FOR THE PREPARATION OF REMIMAZOLAM
[French] PROCÉDÉ DE PRÉPARATION DE REMIMAZOLAM
Applicants **
WAVELENGTH ENTERPRISES LTD 94 Shlomo Smeltzer Road 4970602 Petah Tikva, IL
Inventors
JAGADALE, Vikram S. ,
PATIL, Amol S. ,
BODKHE, Arjun R. ,
JOSHI, Ashutosh V. ,
Priority Data
63/242,185   09.09.2021   US
63/292,176   21.12.2021   US
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
*
International Searching Authority
*
*
Applicant's Legal Status
*
*
*
*
*
Entry into National Phase under
*
Translation

Recalculate

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing1155
EPO Filing, Examination6431
Japan Filing594
South Korea Filing608
USA Filing, Examination2280
MasterCard Visa

Total: 11068

The term for entry into the National Phase has expired. This quotation is for informational purposes only

Abstract[English] A process is described for preparing 3-[(4S)-8-bromo-l-methyl-6-(2-pyridinyl)-4H-imidazo [ 1,2-a] [ 1,4]benzodiazepine-4-yl]propionic acid methyl ester of formula (B) which comprises reacting methyl 3-((3S)-7-bromo-2-(2-hydroxy-propylamino)-5-(pyridin-2-yl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)propanoate of formula (A) with an oxidizing agent which is pyridine sulfur trioxide, chromic acid or a salt thereof.[French] L'invention concerne un procédé de préparation de 3-[(4S)-8-bromo-l-méthyl-6-(2-pyridinyl))-4H-imidazo [1,2-a] [1,4] benzodiazépine-4-yl] propionique de formule (B) qui comprend la réaction de méthyl 3-((3S)-7-bromo-2-(2-hydroxy-propylamino))-5-(pyridin-2-yl))-2,3-dihydro-1H-benzo[e] [1,4]diazépin-3-yl) propanoate de formule (A) avec un agent oxydant qui est du trioxyde de soufre de pyridine, de l'acide chromique ou un sel de celui-ci.
An unhandled error has occurred. Reload 🗙